RNF220 overexpression correlated with poor prognosis in AML, drove an immunosuppressive microenvironment characterized by reduced CD8+ T cells, and inhibited NK activity and M2 polarization of macrophage. Here, RNF220 is linked to acute myeloid leukemia.